Type 2 diabetes glycaemic goals not met by 50 per cent of people
Only half of people with type 2 diabetes are meeting the recommend glycaemic goals despite there being more treatment options available, according to research.
A US study said in the last last 10 years the Food and Drug Administration (FDA) has approved more than 40 new treatment options for the condition, despite that people are still not managing their type 2 diabetes as they should be.
The authors wrote: “Despite our growing understanding of diabetes and the availability of new medications and technologies, a substantial number of individuals are not at their glycaemic goal.”
Data from the National Health and Nutrition Examination Survey indicated only about 50 per cent of American adults with diabetes are achieving HbA1c levels of <7.0 per cent (<53 mmol/mol) and it is estimated only 64 per cent are reaching their individual glycaemic goals.
The number of diagnosed cases of diabetes has increased fourfold from 1980 through to 2014 (from 5.5 million to 22.0 million), with type 2 diabetes making up the vast majority of cases.
Even though there is far greater choice for treatment options available including combination products, these figures suggest they have not “contributed to a meaningful improvement in glycaemic control”.
If diabetes is not controlled it can lead to devastating complications which the study authors said if the “present trends in incidence and prevalence continue without change” they have estimated that one-third of Americans will have diabetes by 2050, which could lead to even higher rates of morbidity and mortality as a result of poor glycaemic control.
The authors concluded in a bid to achieve “meaningful and sustained HbA1c reductions, “we appeal to the diabetes community to drive even harder for innovative approaches designed with the real world in mind”.
To read the study in full, click here.